Rocket Pharmaceuticals, Inc. (RCKT) Stock Grade

About Rocket Pharmaceuticals, Inc.'s fundamentals

Rocket Pharmaceuticals is a biotechnology company with a market capitalization of $390.0 million that reported no revenue growth year-over-year and generated no net margin, reflecting a net loss in its latest annual statement. The company does not pay a dividend. As a development-stage biopharmaceutical firm, traditional valuation metrics like P/E ratio and return on equity are not applicable, which is typical for companies focused on bringing pipeline candidates through clinical development rather than generating current profits.